Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
86 hedge funds and large institutions have $400M invested in Accelerate Diagnostics in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 27 reducing their positions, and 4 closing their positions.
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
26% more capital invested
Capital invested by funds: $317M → $400M (+$82.6M)
15% more funds holding
Funds holding: 75 → 86 (+11)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less call options, than puts
Call options by funds: $1.78M | Put options by funds: $1.87M
15% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 27
Top Buyers
| 1 |
CC
Cannell & Co
New York
|
+$24.3M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$4.66M |
| 3 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
+$2.62M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.59M |
| 5 |
DA
DSC Advisors
Chicago,
Illinois
|
+$1.37M |
Top Sellers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.55M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.08M |
| 3 |
Millennium Management
New York
|
-$630K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$444K |
| 5 |
Morgan Stanley
New York
|
-$357K |
AXDX Hedge Fund Activity: Q2 2015 in Review
86 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q2 2015, worth a combined $400M — up 26% from $317M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AXDX positions and 4 closed out — a net gain of 11 holders — while 23 added to existing stakes and 27 trimmed.
The largest buyer was Cannell & Co, opening a new position worth an estimated $24.3M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.55M.
- 86 institutional investors held Accelerate Diagnostics (AXDX) as of Q2 2015, up from 75 in Q1 2015.
- Funds reported $400M of Accelerate Diagnostics stock for Q2 2015, up 26% quarter-over-quarter.
- 15 funds opened new Accelerate Diagnostics positions in Q2 2015 and 4 closed out, a net change of +11 holders.
- The largest Accelerate Diagnostics buyer in Q2 2015 was Cannell & Co, an estimated $24.3M added.
- The largest Accelerate Diagnostics seller in Q2 2015 was BlackRock Fund Advisors, an estimated $1.55M sold.
Based on aggregated 13F filings for Q2 2015.